Understanding Cablivi Prescribing Information: What You Need to Know
cablivi (caplacizumab), a drug developed by ablynx, was approved in 2018 by the us food and drug administration (fda) for the treatment of adults with acquired thrombotic thrombocytopenic purpura (attp),…